Abstract:The four major comments of muscle wasting disease are cachexia, sarcopenia, malnutrition and congenital.1, 2 Of these, the most common is sarcopenia.3-7 Since sarcopenia is a clinical situation which causes various adverse outcomes, including immobility, falls, disability and death in older people 8-13, the importance of recognizing and treating sarcopenia has been recognized by providing an ICD-10 code for sarcopenia. Since the publication of the European Working Group consensus paper on sarcopenia in older persons,14 a number of other definitions have been published.15-18 All these definitions have stressed that sarcopenia should be defined as a loss of muscle function associated with a loss of muscle mass.19-21 This change in definition was necessitated by the recognition that muscle quality and, therefore, muscle performance were not directly related to muscle mass.22 Two factors appear to be responsible for this, viz the fact that sarcopenia is a neuromuscular junction disease23, 24 and the infiltration of fat into muscle during the ageing process.25, 26 The measurement of muscle mass has classically been done by anthropomorphic measures or dual energy x-ray absorptiometry.27 However, ultrasound, bioelectrical impedance, computed tomography, and magnetic resonance imaging have also been used. Goodman et al.,28 utilizing the NHANES data, suggested that Body Mass Index (BMI) is a reasonable proxy as a skeletal muscle index. Yu et al.29 utilized equations using BMI, weight, and age and showed that these are excellent predictive equations for skeletal muscle mass. A recent review of methods to assess sarcopenia found that for epidemiological studies, bioelectrical impedance for measuring muscle mass coupled with either gait speed or grip dynamometry were the most simple methods to identify sarcopenia based on the modern definitions.30 Recently it was shown that the questions used in the FRAX as part of diagnosis fracture risk had excellent specificity and sensitivity in recognizing risk when used without measuring bone mineral density.31 This raised the possibility that persons with sarcopenia could be identified by a simple questionnaire. This led to the development of SARC-F as a simple questionnaire to rapidly diagnose sarcopenia (Table 1).32, 33 Cao et al.34 showed that SARC-F was associated with poor physical performance, grip strength, and hospitalization in the previous 2 years. Woo et al.35 showed that SARC-F has excellent specificity when identifying persons with sarcopenia diagnosed by either the European or Asian working group definitions. Further, the Hong Kong group showed that SARC-F had similar predictive value for walking speed, physical limitation, hospitalization, and mortality as the Foundation of the National Institutes of Health and four other consensus definitions for sarcopenia.36 Woo et al.37 then showed that it could be used prospectively to successfully screen for sarcopenia. Malmstrom et al.38 showed that the SARC-F was a valid tool in three populations viz the Baltimore Longitudinal study, the African American Cohort in St. Louis, and the NHANES population. Sarcopenia is a major component of physical frailty in older persons.39 The simple FRAIL score has been shown to be a valid measure for detecting frailty.40-42 Between 40 and 70% of persons who are frail are also sarcopenic.37, 43 Thus, it makes sense to screen for both frailty and sarcopenia in older individuals as is done in the Rapid Geriatric Assessment (RGA).44 In addition, middle aged persons with diabetes mellitus,45-47 chronic obstructive pulmonary disease,48, 49 and hip fracture50, 51 are at high risk of having sarcopenia and therefore should be screened. The accumulating evidence shows that sarcopenia could be alleviated by resistance exercise,52-55 leucine enriched essential amino acids,56-58 and vitamin D.59 New promising drugs for sarcopenia are in development. 59 Given that we have a successful treatment which enhances outcome for sarcopenia, it would seem that utilizing the SARC-F, which takes under 15 s to do, to screen older persons and those with specific diseases with a high propensity to become sarcopenic, is an imminently sensible approach to prevent disability and hospitalization in older persons. The importance of recognizing and treating sarcopenia has been recognized by providing an ICD-10 code for sarcopenia. This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant number U1QHP28716 Geriatrics Workforce Enhancement Program for $832 079. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS, or the U.S. Government. The authors certify that they comply with the ethical guidelines for authorship and publishing of the Journal of Cachexia, Sarcopenia, and Muscle (von Haehling S, Morley JE, Coats AJS, Anker SD). Ethical guidelines for authorship and publishing in the Journal of Cachexia, Sarcopenia, and Muscle. J Cachexia Sarcopenia Muscle. 2010;1:7–8. None declared.

235 A clinical audit of detection and management of sarcopenia in a mixed stroke ward in an academic teaching hospital

1894 Enhancing detection of possible sarcopenia and delivery of targeted physiotherapy interventions among hospitalised older patient

Screening, Diagnosis and Management of Sarcopenia and Frailty in Hospitalized Older Adults: Recommendations from the Australian and New Zealand Society for Sarcopenia and Frailty Research (ANZSSFR) Expert Working Group

Effects of sarcopenia on changes in prevalence of patients with depressive mood during hospitalization in geriatric rehabilitation

Sarcopenia in general practice: Towards improving muscle health screening, assessment and management in Australia

Possible Sarcopenia and Its Association with Nutritional Status, Dietary Intakes, Physical Activity and Health-Related Quality of Life among Older Stroke Survivors

Sarcopenia Prevalence and Risk Factors among Residents in Aged Care

Effectiveness of digital health exercise interventions on muscle function and physical performance in older adults with possible, confirmed or severe sarcopenia: a protocol for a systematic review

Sarcopenia knowledge of geriatric rehabilitation patients is low while they are willing to start sarcopenia treatment: EMPOWER-GR

1878 Sarcopenia screening in older community-dwelling adults: findings from Southampton Longitudinal Study of Ageing (SaLSA)

Interventions to ameliorate reductions in muscle quantity and function in hospitalised older adults: a systematic review towards acute sarcopenia treatment

RISK OF SARCOPENIA AND ASSOCIATED FACTORS IN HOSPITALIZED OLDER ADULTS WITH CARDIOVASCULAR DISEASE

Protocol for understanding acute sarcopenia: a cohort study to characterise changes in muscle quantity and physical function in older adults following hospitalisation

Sarcopenia and Associated Factors in Adults Aged 40 and Above: A Study Conducted in Primary Healthcare

Rapid Screening for Sarcopenia

The feasibility and validity of sarcopenia assessment using standard of care stroke imaging.

Evaluation of Probable Sarcopenia’s Prevalence in Hospitalized Geriatric Patients Using Ishii’s Score

Sarcopenia Predicts Readmission and Mortality in Elderly Patients in Acute Care Wards: a Prospective Study.

Obstacles to the Early Diagnosis and Management of Sarcopenia: Current Perspectives

Effectiveness of Cardiac Rehabilitation for Prevention and Treatment of Sarcopenia in Patients with Cardiovascular Disease - A Retrospective Cross-Sectional Analysis

#2080 Prevalence and development of sarcopenia in chronic hemodialysis patients, a single center, prospective, observational study